INTRAVENOUS IMMUNOGLOBULIN AMELIORATESIMMUNE THROMBOCYTOPENIA THROUGH MODULATING THE SELECTIN PATHWAYS
博士 === 慈濟大學 === 醫學研究所 === 98 === Intravenous immunoglobulin (IVIg) treatments have been used for decades to the autoantibody-mediated thrombocytopenia and ischemia-induced inflammatory responses. Previous studies suggested that IVIg exerts its anti-inflammatory effects through selectin pathways, bec...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2010
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/09085618998648756321 |